Page 63 - MI-1-1
P. 63

Microbes & Immunity                                          Benefit of noninvasive VNS in vaccine optimization



               doi: 10.1111/cen3.12703                            A pilot randomized clinical trial. Expert Rev Med Devices.
                                                                  2022;19(11):915920.
            38.  Rangon CM, Niezgoda A. Understanding the pivotal role of
               the vagus nerve in health from pandemics. Bioengineering.      doi: 10.1080/17434440.2022.2154147
               2022;9(8):352.                                  48.  Jankauskaite L, Malinauskas M, Mickeviciute GC.
               doi: 10.3390/bioengineering9080352                 HMGB1: A potential target of nervus vagus stimulation in
                                                                  pediatric  SARS-CoV-2-induced  ALI/ARDS.  Front Pediatr.
            39.  Wang Q, Iketani S, Li Z, et al. Alarming antibody evasion   2022;10:884539.
               properties of rising SARS-CoV-2 BQ and XBB subvariants.
               Cell. 2023;186(2):279-286.e8.                      doi: 10.3389/fped.2022.884539
               doi: 10.1016/j.cell.2022.12.018                 49.  Chrestia  JF,  Oliveira  AS,  Mulholland  AJ,  Gallagher  T,
                                                                  Bermúdez I, Bouzat C. A  Functional interaction between
            40.  Terliesner N, Unterwalder N, Edelmann A,  et al. Viral   Y674-R685 region of the SARS-CoV-2 Spike protein
               infections in hospitalized children in Germany during the   and the human  α7 nicotinic receptor.  Mol Neurobiol.
               COVID-19 pandemic: Association with non-pharmaceutical   2022;59(10):60766090.
               interventions. Front Pediatr. 2022;10:935483.
                                                                  doi: 10.1007/s12035-022-02947-8
               doi: 10.3389/fped.2022.935483
                                                               50.  Doria D, Santin AD, Tuszynski JA, Scheim DE,
            41.  Jacinto CP, Gastaldi AC, Aguiar DY, Maida KD, Souza HCD.   Aminpour  M. Omicron SARS-CoV-2 Spike-1 protein’s
               Physical therapy for airway clearance improves cardiac   decreased binding affinity to  α7nAChr: Implications for
               autonomic modulation in children with acute bronchiolitis.   autonomic  dysregulation  of  the  parasympathetic  nervous
               Braz J Phys Ther. 2013;17(6):533540.               system and the cholinergic anti-inflammatory pathway-an
               doi: 10.1590/S1413-35552012005000120               in silico analysis. BioMedInformatics. 2022;2(4):553564.
            42.  Staats P, Giannakopoulos G, Blake J, Liebler E, Levy RM.      doi: 10.3390/biomedinformatics2040035
               The use of non-invasive vagus nerve stimulation to   51.  Woo MS,  Shafiq  M, Fitzek A,  et  al. Vagus  nerve
               treat respiratory symptoms associated with COVID-19:   inflammation contributes to dysautonomia in COVID-19.
               A  theoretical  hypothesis  and early  clinical  experience.   Acta Neuropathol. 2023;146(3):387394.
               Neuromodulation. 2020;23(6):784788.
                                                                  doi: 10.1007/s00401-023-02612-x
               doi: 10.1111/ner.13172
                                                               52.  Tanmay S, Labrou D, Farsalinos K, Poulas K. Is SARS-CoV-2
            43.  Seitz T, Szeles JC, Kitzberger R, et al. Percutaneous auricular   spike glycoprotein impairing macrophage function via
               vagus nerve stimulation reduces inflammation in critical   α7-nicotinic acetylcholine receptors?  Food Chem Toxicol.
               Covid-19 patients. Front Physiol. 2022;13:897257.  2021;152:112184.
               doi: 10.3389/fphys.2022.897257                     doi: 10.1016/j.fct.2021.112184
            44.  Tornero C, Pastor E, Garzando MM,  et al. Non-invasive   53.  Godellas NE, Cymes GD, Grosman C. An experimental test
               vagus nerve stimulation for COVID-19: Results from a   of the nicotinic hypothesis of COVID-19. Proc Natl Acad Sci
               randomized  controlled  trial  (SAVIOR  I).  Front Neurol.   U S A. 2022;119(44):e2204242119.
               2022;13:820864.
                                                                  doi: 10.1073/pnas.2204242119
               doi: 10.3389/fneur.2022.820864
                                                               54.  Zoli  M,  Pucci  S,  Vilella  A,  Gotti  C.  Neuronal  and
            45.  Rangon CM, Barruet R, Mazouni A,  et al. Auricular   extraneuronal nicotinic  acetylcholine receptors.  Curr
               neuromodulation  for  mass  vagus  nerve  stimulation:   Neuropharmacol. 2018;16(4):338349.
               Insights from SOS COVID-19 a multicentric, randomized,
               controlled, double-blind French pilot study. Front Physiol.      doi: 10.2174/1570159X15666170912110450
               2021;12:704599.                                 55.  Bulfamante G, Bocci T, Falleni M, Campiglio L, Coppola S,
               doi: 10.3389/fphys.2021.704599                     Tosi D,  et al.  Brainstem neuropathology in two cases of
                                                                  COVID-19: SARS-CoV-2 trafficking between brain and
            46.  Boezaart AP, Botha DA. Treatment of stage 3 COVID-19   lung. J Neurol. 2021;268(12):4486-91.
               with  transcutaneous  auricular  vagus  nerve  stimulation
               drastically reduces interleukin-6 blood levels: A report on      doi: 10.1007/s00415-021-10604-8
               two cases. Neuromodulation. 2021;24(1):166167.  56.  Basha S, Surendran N, Pichichero M. Immune responses in
               doi: 10.1111/ner.13293                             neonates. Expert Rev Clin Immunol. 2014;10(9):11711184.
            47.  Uehara  L,  Corrêa  JCF,  Ritti  R,  et al.  Transcutaneous      doi: 10.1586/1744666X.2014.942288
               auricular vagus nerve stimulation effects on inflammatory   57.  Cooper DM, Afghani B, Byington CL, et al. SARS-CoV-2
               markers and clinical evolution of patients with COVID-19:   vaccine testing and trials in the pediatric population:


            Volume 1 Issue 1 (2024)                         57                               doi: 10.36922/mi.2598
   58   59   60   61   62   63   64   65   66   67   68